Phathom Pharmaceuticals (PHAT) Earnings Date, Estimates & Call Transcripts → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free PHAT Stock Alerts $9.67 +0.14 (+1.47%) (As of 05/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 9) -$1.42 Beat By $0.01 Consensus EPS (May. 9) -$1.43 Listen to Call Get Phathom Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for PHAT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePHAT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PHAT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Phathom Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($5.41) EPSNext Year EPS Consensus Estimate: ($4.18) EPSPHAT Earnings Date and InformationPhathom Pharmaceuticals last announced its quarterly earnings data on May 9th, 2024. The reported ($1.42) EPS for the quarter, topping the consensus estimate of ($1.43) by $0.01. The firm earned $1.91 million during the quarter, compared to the consensus estimate of $2.76 million. Phathom Pharmaceuticals has generated ($4.41) earnings per share over the last year (($4.41) diluted earnings per share). Earnings for Phathom Pharmaceuticals are expected to grow in the coming year, from ($5.41) to ($4.18) per share. Phathom Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Phathom Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024Estimated)------- 5/9/2024Q1 2024($1.43)($1.42)+$0.01($1.42)$2.76 million$1.91 million 3/7/2024Q4 2023($0.92)($0.80)+$0.12($0.21)$0.93 million$0.68 million 11/9/2023Q3 2023($0.95)($0.76)+$0.19($0.76)--8/10/2023Q2 2023($0.95)($0.84)+$0.11($0.84)--5/10/2023Q1 2023($1.34)($0.89)+$0.45($0.89)--2/28/2023Q4 2022($1.50)($1.33)+$0.17($1.33)-- Get the Latest News and Ratings for PHAT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/8/2022Q3 2022-($1.32)($1.32)($1.32)--8/2/2022Q2 2022-($1.33)($1.33)($1.33)--5/10/2022Q1 2022-($1.07)($1.07)($1.07)--3/1/2022Q4 2021($0.86)($0.95)($0.09)($0.95)--11/8/2021Q3 2021($1.05)($0.98)+$0.07($0.98)--8/10/2021Q2 2021($1.07)($1.00)+$0.07($1.00)-- Phathom Pharmaceuticals Earnings - Frequently Asked Questions When is Phathom Pharmaceuticals's earnings date? Phathom Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on PHAT's earnings history. Did Phathom Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Phathom Pharmaceuticals (NASDAQ:PHAT) reported ($1.42) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.43) by $0.01. Learn more on analysts' earnings estimate vs. PHAT's actual earnings. How can I listen to Phathom Pharmaceuticals's earnings conference call? The conference call for Phathom Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Phathom Pharmaceuticals generate each year? Phathom Pharmaceuticals (NASDAQ:PHAT) has a recorded annual revenue of $680,000.00. How much profit does Phathom Pharmaceuticals generate each year? Phathom Pharmaceuticals (NASDAQ:PHAT) has a recorded net income of -$201.59 million. PHAT has generated -$4.41 earnings per share over the last four quarters. What is Phathom Pharmaceuticals's EPS forecast for next year? Phathom Pharmaceuticals's earnings are expected to grow from ($5.41) per share to ($4.18) per share in the next year. More Earnings Resources from MarketBeat Related Companies: IGMS Earnings Results CALT Earnings Results STOK Earnings Results AVTE Earnings Results GHRS Earnings Results OLMA Earnings Results CDMO Earnings Results ZYME Earnings Results PHAR Earnings Results LYEL Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:PHAT) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phathom Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.